Literature DB >> 29035283

mTORC1 stimulates phosphatidylcholine synthesis to promote triglyceride secretion.

William J Quinn1, Min Wan1, Swapnil V Shewale2, Rebecca Gelfer1, Daniel J Rader2, Morris J Birnbaum1,3, Paul M Titchenell1,4.   

Abstract

Liver triacylglycerol (TAG) synthesis and secretion are closely linked to nutrient availability. After a meal, hepatic TAG formation from fatty acids is decreased, largely due to a reduction in circulating free fatty acids (FFA). Despite the postprandial decrease in FFA-driven esterification and oxidation, VLDL-TAG secretion is maintained to support peripheral lipid delivery and metabolism. The regulatory mechanisms underlying the postprandial control of VLDL-TAG secretion remain unclear. Here, we demonstrated that the mTOR complex 1 (mTORC1) is essential for this sustained VLDL-TAG secretion and lipid homeostasis. In murine models, the absence of hepatic mTORC1 reduced circulating TAG, despite hepatosteatosis, while activation of mTORC1 depleted liver TAG stores. Additionally, mTORC1 promoted TAG secretion by regulating phosphocholine cytidylyltransferase α (CCTα), the rate-limiting enzyme involved in the synthesis of phosphatidylcholine (PC). Increasing PC synthesis in mice lacking mTORC1 rescued hepatosteatosis and restored TAG secretion. These data identify mTORC1 as a major regulator of phospholipid biosynthesis and subsequent VLDL-TAG secretion, leading to increased postprandial TAG secretion.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29035283      PMCID: PMC5663357          DOI: 10.1172/JCI96036

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways.

Authors:  Jessica L Yecies; Hui H Zhang; Suchithra Menon; Sihao Liu; Derek Yecies; Alex I Lipovsky; Cem Gorgun; David J Kwiatkowski; Gökhan S Hotamisligil; Chih-Hao Lee; Brendan D Manning
Journal:  Cell Metab       Date:  2011-07-06       Impact factor: 27.287

2.  The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes.

Authors:  Z M Yao; D E Vance
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

3.  mTORC1 controls fasting-induced ketogenesis and its modulation by ageing.

Authors:  Shomit Sengupta; Timothy R Peterson; Mathieu Laplante; Stephanie Oh; David M Sabatini
Journal:  Nature       Date:  2010-12-23       Impact factor: 49.962

4.  Activation of ER stress and mTORC1 suppresses hepatic sortilin-1 levels in obese mice.

Authors:  Ding Ai; Juan M Baez; Hongfeng Jiang; Donna M Conlon; Antonio Hernandez-Ono; Maria Frank-Kamenetsky; Stuart Milstein; Kevin Fitzgerald; Andrew J Murphy; Connie W Woo; Alanna Strong; Henry N Ginsberg; Ira Tabas; Daniel J Rader; Alan R Tall
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

Review 5.  The emerging roles of lipids in circadian control.

Authors:  Yaarit Adamovich; Rona Aviram; Gad Asher
Journal:  Biochim Biophys Acta       Date:  2014-12-04

6.  Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients.

Authors:  Joel D Morrisett; Ghada Abdel-Fattah; Ron Hoogeveen; Eddie Mitchell; Christie M Ballantyne; Henry J Pownall; Antone R Opekun; Jonathon S Jaffe; Suzanne Oppermann; Barry D Kahan
Journal:  J Lipid Res       Date:  2002-08       Impact factor: 5.922

7.  Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis.

Authors:  Aaron M Robitaille; Stefan Christen; Mitsugu Shimobayashi; Marion Cornu; Luca L Fava; Suzette Moes; Cristina Prescianotto-Baschong; Uwe Sauer; Paul Jenoe; Michael N Hall
Journal:  Science       Date:  2013-02-21       Impact factor: 47.728

8.  Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice.

Authors:  Seongah Han; Chien-Ping Liang; Marit Westerterp; Takafumi Senokuchi; Carrie L Welch; Qizhi Wang; Michihiro Matsumoto; Domenico Accili; Alan R Tall
Journal:  J Clin Invest       Date:  2009-03-09       Impact factor: 14.808

9.  Hyperinsulinemia and in vivo very-low-density lipoprotein-triglyceride kinetics.

Authors:  G Steiner; F J Haynes; G Yoshino; M Vranic
Journal:  Am J Physiol       Date:  1984-02

Review 10.  Selective hepatic insulin resistance, VLDL overproduction, and hypertriglyceridemia.

Authors:  Janet D Sparks; Charles E Sparks; Khosrow Adeli
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-07-12       Impact factor: 8.311

View more
  24 in total

1.  To absorb fat - supersize my lipid droplets.

Authors:  Ira J Goldberg; M Mahmood Hussain
Journal:  J Clin Invest       Date:  2018-12-03       Impact factor: 14.808

2.  Lipin 2/3 phosphatidic acid phosphatases maintain phospholipid homeostasis to regulate chylomicron synthesis.

Authors:  Peixiang Zhang; Lauren S Csaki; Emilio Ronquillo; Lynn J Baufeld; Jason Y Lin; Alexis Gutierrez; Jennifer R Dwyer; David N Brindley; Loren G Fong; Peter Tontonoz; Stephen G Young; Karen Reue
Journal:  J Clin Invest       Date:  2018-12-03       Impact factor: 14.808

3.  Food Perception Primes Hepatic ER Homeostasis via Melanocortin-Dependent Control of mTOR Activation.

Authors:  Claus Brandt; Hendrik Nolte; Sinika Henschke; Linda Engström Ruud; Motoharu Awazawa; Donald A Morgan; Paula Gabel; Hans-Georg Sprenger; Martin E Hess; Stefan Günther; Thomas Langer; Kamal Rahmouni; Henning Fenselau; Marcus Krüger; Jens C Brüning
Journal:  Cell       Date:  2018-11-15       Impact factor: 41.582

Review 4.  Mechanisms of Insulin Action and Insulin Resistance.

Authors:  Max C Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

5.  mTORC1-IRE1α pathway activation contributes to palmitate-elicited triglyceride secretion and cell death in hepatocytes.

Authors:  Jun Wang; Yingli Chen; Qing Song; Alexandra Griffiths; Zhenyuan Song
Journal:  Exp Biol Med (Maywood)       Date:  2020-05-21

6.  Thioesterase Superfamily Member 2 Promotes Hepatic VLDL Secretion by Channeling Fatty Acids Into Triglyceride Biosynthesis.

Authors:  Michele Alves-Bezerra; Yingxia Li; Mariana Acuña; Anna A Ivanova; Kathleen E Corey; Eric A Ortlund; David E Cohen
Journal:  Hepatology       Date:  2019-03-22       Impact factor: 17.425

Review 7.  Molecular logic of mTORC1 signalling as a metabolic rheostat.

Authors:  Alexander J Valvezan; Brendan D Manning
Journal:  Nat Metab       Date:  2019-03-04

8.  Effects of Haloperidol, Risperidone, and Aripiprazole on the Immunometabolic Properties of BV-2 Microglial Cells.

Authors:  Valentino Racki; Marina Marcelic; Igor Stimac; Daniela Petric; Natalia Kucic
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

9.  Something to mTORC About in NASH.

Authors:  Brian N Finck
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2022-04-02

10.  mTORC1 activation is not sufficient to suppress hepatic PPARα signaling or ketogenesis.

Authors:  Ebru S Selen; Michael J Wolfgang
Journal:  J Biol Chem       Date:  2021-06-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.